General
information for jHASE authors
Prospective authors are advised to also read
About this journal,
which includes other relevant information.
Submission
process
To facilitate rapid publication and to minimize
administrative costs, jHASE currently accepts submissions
through the
online journal system (OJS) with attachments of
article text and figures/illustrations formatted
according to additional instructions for authors
provided in this document for each article type.
Publication
and peer review processes
Unless they are outside the scope for the journal or are of
an unacceptably low standard of presentation, submitted
articles will be sent to peer reviewers. They will
generally be reviewed by 2-3 subject experts with the aim of
reaching a first decision as soon as possible. Section
Editors are assisted by peer-review fellows with
consolidation of reviewer reports or with any additional
literature reference work that may be needed. Statistical reviewers are also used where required,
as determined by the Section Editor. Reviewers are asked to declare any competing
interests and have to agree to open peer review, which
works on two levels: the authors receive the signed
report and, if the manuscript is published, the same
report is available to the readers. The pre-publication
history (initial submission, reviews and revisions -
see, for example, pre-publication
history) may be posted on the web with the published
article or made available on request.
To expedite
publication and reduce costs of developing a large pool
of relevant peer reviewers, jHASE requires that all authors
provide the contact details (including e-mail addresses)
of at least four to five (4-5) potential peer reviewers for their
manuscript. These should be knowledgeable on the
topic of the manuscript submitted as they need to be
able to provide an objective assessment of the
manuscript. Any suggested peer reviewers should not have
published with any of the authors of the manuscript
within the past five years and should not be members of
the same research institution. Members of the Advisory
Editorial Board
can be nominated, except Editor(s)-in-Chief,
Associate/Senior Editors, Section Editors, and Managing
Editors of the journal. Suggested reviewers will be considered
alongside potential reviewers identified by their
publication record or recommended by Editorial Board
members. To leave this page and read more information on
requirements for qualifications and experience of peer
reviewers for jHASE publications,
click here.
Reviewers are asked
whether the manuscript is scientifically sound and
coherent, how interesting it is and whether the quality
of the writing is acceptable. Where possible, the final
decision is made on the basis that the peer reviewers
are in accordance with one another, or that at least
there is no strong dissenting view. In cases where there
is strong disagreement either among peer reviewers or
between the authors and peer reviewers, advice is sought
from a panel of senior members of the journal's Editorial Board. The
journal allows a maximum of two revisions of any
manuscripts. The ultimate responsibility for any peer
review decision lies with the Editors-in-Chief.
Reviewers are also asked
to indicate which articles they consider to be
especially interesting or significant. These articles
may be given greater prominence and greater external
publicity.
Once an
article is accepted, it is published in jHASE
immediately as a provisional PDF file. The paper will
be subsequently published in both fully browseable web
form, and as a formatted PDF; the article will then be
available through jHASE (published by IEPH, Inc.) and
indexed and archived in the
World Health Organization(WHO)-sponsored African Index
Medicus(AIM) and searchable through
Google Scholar Search for AIM . jHASE expects to
have it's AIM-indexed publications to be retroactively
cross-indexed in Pubmed Medline after about 12 months of publication track-record,
which is what's typically required to
qualify for Medline indexing. Following publication in jHASE, the full text of each article is immediately and
permanently archived in IEPH's literature repository
(pending archiving in PubMed Central, the US National
Library of Medicine's full-text repository of life
science literature and indexing in MEDLINE).
At this
time, authors
may track the progress of their
paper at any time by logging in to the jHASE
online journal system (OJS).
Article-processing
charges
To ensure that all
worthy and accepted manuscripts can be published in jHASE regardless of
the authors' ability to pay, jHASE routinely waives
article-processing charges for qualifying
authors . For further details, please see
more
information about article-processing charges.
Supplemental editorial
policies
Any
manuscript submitted to the journal must not already
have been published in another journal or be under
consideration by any other journal, although it may have
been deposited on a preprint server. Manuscripts that
are derived from papers presented at conferences can be
submitted unless they have been published as part of the
conference proceedings in a peer reviewed journal.
Authors are required to ensure that no material
submitted as part of a manuscript infringes existing
copyrights, or the rights of a third party. Authors who
publish in jHASE retain copyright to their work (more
information on license). Correspondence concerning articles
published in jHASE is encouraged.
Submission
of a manuscript to jHASE implies that all authors
have read and agreed to its content, and that any
experimental research on humans or animals that is
reported in the manuscript has been performed with the
approval of an appropriate ethics committee, and is in
compliance with the Helsinki
Declaration. A statement to this effect must be
included in the Methods section of the manuscript.
Generic drug names should generally be used. When
proprietary brands are used in research, include the
brand names in parentheses in the Methods section.
We ask
authors of jHASE papers to complete a declaration
of competing interests, which should be provided as
a separate section of the manuscript, to follow the
Acknowledgements. Where an author gives no competing
interests, the listing will read 'The author(s) declare
that they have no competing interests'. Much has been
written about competing interests (or conflict of
interest, as other journals call it) within scientific
research, but the following articles provide some
background:
R
Smith: Beyond conflict of interest. BMJ
1998, 317:291-292
R
Smith: Making progress with competing interests.
BMJ 2002, 325:1375-1376
CD
DeAngelis, PB Fontanarosa, A Flanagin: Reporting
financial conflicts of interest and relationships
between investigators and research sponsors. JAMA
2001, 286:89-9
K
Morin, H Rakatansky, FA Riddick Jr, LJ Morse, JM
O'Bannon 3rd, MS Goldrich, P Ray, M Weiss, RM Sade, MA
Spillman: Managing conflicts of interest in the
conduct of clinical trials. JAMA 2002, 287:78-84
For all
articles that include information or clinical
photographs relating to individual patients, written and
signed consent from each patient to publish must also be
mailed or faxed to the editorial staff. The manuscript
should also include a statement to this effect in the
Acknowledgements section, as follows: "Written
consent was obtained from the patient or their relative
for publication of study".
jHASE
and its publisher, IEPH, Inc., support initiatives to improve the performance and
reporting of clinical trials, part of which includes
prospective registering and numbering of trials. While
there are initiatives to ensure that all clinical trials
are registered (most notably the recent statement from
the International Committee of Medical Journal Editors -
see http://www.icmje.org/clin_trial.pdf),
we are focussing on randomised controlled trials, for
now. Authors of protocols or reports of randomised
controlled trials must register their trial prior to
submission in a publicly accessible registry. The trial
registration number must be included in the title of the
manuscript. One such number is the International
Standard Randomised Controlled Trial Number (ISRCTN),
which can be obtained by completing an online
application form http://www.controlled-trials.com/isrctn/submission/.
jHASE
and its publisher, IEPH, Inc., also support initiatives aimed at improving the
reporting of biomedical research. Checklists have been
developed for randomized controlled trials (CONSORT),
systematic reviews (QUORUM),
and meta-analyses of observational studies (MOOSE).
Authors are requested to make use of these when drafting
their manuscript and peer reviewers will also be asked
to refer to these checklists when evaluating these
studies. For authors of systematic reviews, a
supplementary file, linked from the Methods section,
should reproduce all details concerning the search
strategy. For an example of how a search strategy should
be presented, see the Cochrane
Reviewers' Handbook.
Authors
from pharmaceutical companies, or other commercial
organizations that sponsor clinical trials, should
adhere to the Good
Publication Practice guidelines for pharmaceutical
companies, which are designed to ensure that
publications are produced in a responsible and ethical
manner. The guidelines also apply to any companies or
individuals that work on industry-sponsored
publications, such as freelance writers, contract
research organizations and communications companies.
Submission
of a manuscript to jHASE implies that readily
reproducible materials described in the manuscript will
be freely available to any scientist wishing to use them
for non-commercial purposes. Nucleic acid sequences,
protein sequences, and atomic coordinates should be
deposited in an appropriate database in time for the
accession number to be included in the published
article. In computational studies where the sequence
information is unacceptable for inclusion in databases
because of lack of experimental validation, the
sequences must be published as an additional file with
the article. Where appropriate, authors should adhere to
the standards proposed by the Microarray Gene Expression
Data Society (http://www.mged.org)
and must deposit microarray data in one of the public
repositories, such as ArrayExpress (http://www.ebi.ac.uk/arrayexpress),
Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/projects/geo/)
or the Center for Information Biology Gene Expression
Database (CIBEX; http://cibex.nig.ac.jp).
Any 'in press' articles
cited within the references and necessary for the
reviewers' assessment of the manuscript should be made
available if requested by the editorial office.
The publisher of jHASE,
IEPH, Inc., subscribes to the guidelines and code of
conduct of the Committee on Publication Ethics (COPE);
for more information, visit www.publicationethics.org.uk
|
|
return
to top |
Preparing
main manuscript text for jHASE article submissions
File
formats
The following word processor file formats are acceptable
for the main manuscript document:
- Microsoft
Word (version 2 and above, compatible with Word 2000
- 2003)
- WordPerfect
(version 5 and higher versions compatible with Word
2000 - 2003)
- Rich
text format (RTF)
Users of
other word processing packages should save or convert
their files to RTF before uploading. Many free tools are
available which ease this process.
PLEASE
NOTE: Figures must be submitted
as separate image files, not as part of the submitted
DOC/RTF/PDF file.
Please
read the descriptions of each of the article types,
choose which is appropriate for your article and
structure it accordingly. If in doubt, your manuscript
should be classified as a Research article, the
structure for which is described below.
Manuscript
sections/Research article format
Manuscripts for Research articles submitted to jHASE
should be divided into the following sections:
You can download
a template (Mac and Windows compatible; Microsoft
Word 98/2000) for your article. For instructions on use,
see below.
The Accession
Numbers of any nucleic acid sequences, protein
sequences or atomic coordinates cited in the manuscript
should be provided, in square brackets and include the
corresponding database name; for example,
[EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812,
GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7,
PIR:S66116].
The
databases for which we can provide direct links are:
EMBL Nucleotide Sequence Database (EMBL),
DNA Data Bank of Japan (DDBJ
), GenBank at the NCBI (GenBank),
Protein Data Bank (PDB),
Protein Information Resource (PIR)
and the Swiss-Prot Protein Database (Swiss-Prot).
- Title
page
This should list the title of the article. The title
should include the study design, for example:
A
versus B in the treatment of C: a randomized
controlled trial
X
is a risk factor for Y: a case control study
Randomized
controlled trials should include a trial registration
number in square brackets at the end of the title. One
such number is the International
Standard Randomised Controlled Trial Number (ISRCTN).
For an example, see the BAFTA
trial.
The
full names, institutional addresses, and e-mail
addresses for all authors must be included on the
title page. The corresponding author should also be
indicated.
-
Abstract
The abstract of the manuscript should not exceed 350
words and must be structured into four separate
sections: Objectives and Background,
the purpose of the study and context; Methods,
design, how the study was performed and statistical
analyses used; Results, the main findings; Conclusions,
brief summary and potential implications. Please
minimize the use of abbreviations and do not cite
references in the abstract.
-
Objectives,
Background and Rationale
The objectives/purpose/aims of the study must be
described clearly and concisely. The background section should
be written from the standpoint of researchers
without specialist knowledge in that area and must
clearly state - and, if not implicitly obvious, the rationale for the research must be explicitly
stated. Reports of research should, where appropriate, include a
summary of the hypotheses, a review of the literature to indicate
the background of what is known about the
subject to further illuminate the rationale for why this study was necessary and
objectives/what it aimed to contribute to the field.
The section should, where appropriate, end with a
very brief statement of what is being reported in
the article.
-
Methods
This should include the design of the study, the
setting, the type of participants/study population
or materials involved, a clear description of all
study procedures, interventions and comparisons, and
the type of statistical analyses methods used,
including a power calculation if appropriate.
-
Results
and Discussion
The Results and Discussion may be combined into a
single section or presented separately. Results of
statistical analysis should include, where
appropriate, relative and absolute risks or risk
reductions, and confidence intervals. The results
and discussion sections may also be broken into
subsections with short, informative headings.
-
List
of abbreviations
If abbreviations are used in the text either they
should be defined in the text where first used, or a
list of abbreviations can be provided, which should
precede the competing interests and authors'
contributions.
Authors are required to
complete a declaration of competing interests. All
competing interests that are declared will be listed
at the end of published articles. Where an author
gives no competing interests, the listing will read
'The author(s) declare that they have no competing
interests'.
When
completing your declaration, please consider the
following questions:
Financial competing
interests
- In the past five years
have you received reimbursements, fees, funding, or
salary from an organization that may in any way gain
or lose financially from the publication of this
manuscript, either now or in the future? Is such an
organization financing this manuscript (including
the article-processing charge)? If so, please
specify.
- Do you hold any stocks
or shares in an organization that may in any way
gain or lose financially from the publication of
this manuscript, either now or in the future? If so,
please specify.
- Do you hold or are you
currently applying for any patents relating to the
content of the manuscript? Have you received
reimbursements, fees, funding, or salary from an
organization that holds or has applied for patents
relating to the content of the manuscript? If so,
please specify.
- Do you have any other
financial competing interests? If so, please
specify.
Non-financial
competing interests
Are there any
non-financial competing interests (political,
personal, religious, academic, intellectual,
commercial or any other) to declare in relation to
this manuscript? If so, please specify.
If you are unsure as to
whether you, or one your co-authors, has a competing
interest please discuss it with the editorial office.
An "author"
is generally considered to be someone who has made
substantive intellectual contributions to a published
study. To qualify as an author one should have
contributed to substantial aspects of each of the
following: 1) have made
substantial contributions to conception and design of
key aspects; 2)
acquisition of data, or planning/implementing analysis and interpretation of
data; 3) have been involved in drafting the article or
revising it critically for important/substantive intellectual
content (see section below on acknowledgements for
appropriate recognition of those whose contribution is
mainly to organization, presentation, look and feel); and
4) have given final approval of the
version to be published. Each author should have
participated sufficiently in the work to take public
responsibility for appropriate portions of the
content. PLEASE NOTE: Acquisition of funding, collection of data/acquisition
of data,
or general supervision of the research group , alone,
does not justify authorship
(for contributions which
are mainly supervisory,
please see section below
on acknowledgements for appropriate recognition of
those whose contribution is mainly in this regard).
jHASE strongly discourages and disqualifies
manuscripts violating the above principles of
authorship.
We suggest the
following kind of format (please use initials to refer
to each author's main contribution) with 2 sections as
per example below:
Individual authors' main contributions: AB carried out the
molecular genetic studies, participated in the
sequence alignment and drafted the manuscript. JY
carried out the immunoassays. MT participated in the
sequence alignment. ES participated in the design of
the study and performed the statistical analysis. FG
conceived of the study, and participated in its design
and coordination and helped to draft the manuscript.
All authors contributed to:
1) conception and design
of key aspects; 2)
acquisition of data, or planning/implementing analysis and interpretation of
data; 3) drafting the article or
revising it critically for important/substantive intellectual
content; and
4) read and approved the final manuscript.
All contributors who do
not meet the criteria for authorship should be listed
in an acknowledgments section. Examples of those who
might be acknowledged include a person who provided
purely technical help, writing assistance, or a
department chair who provided only general support.
-
References
All references must be numbered consecutively, in
square brackets, in the order in which they are
cited in the text, followed by any in tables or
legends. Each reference must have an individual
reference number. Please avoid excessive
referencing. If automatic numbering systems are
used, the reference numbers must be finalized and
the bibliography must be fully formatted before
submission.
Only
articles and abstracts that have been published or are
in press, or are available through public
e-print/preprint servers, may be cited; unpublished
abstracts, unpublished data and personal
communications should not be included in the reference
list, but may be included in the text. Notes/footnotes
are not allowed. Obtaining permission to quote
personal communications and unpublished data from the
cited author(s) is the responsibility of the author.
Journal abbreviations follow Index Medicus/MEDLINE.
Citations in the reference list should contain all
named authors, regardless of how many there are. There
should usually be no more than 50 references per
article.
We
encourage authors to use a recent version of EndNote
(version 5 and above, compatible with version 10) or Reference Manager (compatible
with version
10) when formatting their reference list, as this
allows references to be automatically extracted.
Authors submitting articles in EndNote 5 or higher (compatible
with version 10) or
Reference Manager 10 format will save 10% on the $1000 article processing charge
(for authors with applicable article processing
charges). In order
to obtain this discount, you should submit the
manuscript file containing your EndNote (or
later versions compatible with version 10) or Reference
Manager-formatted bibliography as a .doc file
compatible with Word 2003. Your invoice will reflect this discount and you will receive confirmation by email.
Subsequent to submission of your article, you will also be able to preview an HTML
version of the extracted references,
and will receive a URL on the invoice. EndNote (or
later versions compatible with version 10) or
Reference Manager users should also make sure that any
changes made to the reference list are done within
their reference management program, rather than by
manually editing the formatted bibliography. This is
because manually introduced changes will not be picked
up in the automatically extracted list.
Further
details about EndNote
and Reference
Manager are available on their respective sites,
including information about how to upgrade.
Links
Web links and URLs should be included in the reference
list. They should be provided in full, including both
the title of the site and the URL, in the following
format: The Mouse Tumor Biology Database
[http://tumor.informatics.jax.org/cancer_links.html]
jHASE
reference style
Article
within a journal
1. Koonin EV, Altschul SF, Bork P: BRCA1 protein
products: functional motifs. Nat Genet
1996, 13:266-267.
Article
within a journal supplement
2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe
I: Analysis and assessment of ab initio
three-dimensional prediction, secondary structure, and
contacts prediction. Proteins 1999, Suppl
3:149-170.
In
press article
3. Kharitonov SA, Barnes PJ: Clinical aspects of
exhaled nitric oxide. Eur Respir J, in
press.
Published
abstract
4. Zvaifler NJ, Burger JA, Marinova-Mutafchieva L,
Taylor P, Maini RN: Mesenchymal cells, stromal
derived factor-1 and rheumatoid arthritis [abstract]. Arthritis
Rheum 1999, 42:s250.
Article
within conference proceedings
5. Jones X: Zeolites and synthetic mechanisms.
In Proceedings of the First National Conference on
Porous Sieves: 27-30 June 1996; Baltimore. Edited
by Smith Y. Stoneham: Butterworth-Heinemann;
1996:16-27.
Book
chapter, or article within a book
6. Schnepf E: From prey via endosymbiont to
plastids: comparative studies in dinoflagellates.
In Origins of Plastids. Volume 2. 2nd edition.
Edited by Lewin RA. New York: Chapman and Hall;
1993:53-76.
Whole
issue of journal
7. Ponder B, Johnston S, Chodosh L (Eds): Innovative
oncology. In Breast Cancer Res 1998, 10:1-72.
Whole
conference proceedings
8. Smith Y (Ed): Proceedings of the First National
Conference on Porous Sieves: 27-30 June 1996;
Baltimore. Stoneham: Butterworth-Heinemann; 1996.
Complete
book
9. Margulis L: Origin of Eukaryotic Cells. New
Haven: Yale University Press; 1970.
Monograph
or book in a series
10. Hunninghake GW, Gadek JE: The alveolar
macrophage. In Cultured Human Cells and
Tissues. Edited by Harris TJR. New York: Academic
Press; 1995:54-56. [Stoner G (Series Editor): Methods
and Perspectives in Cell Biology, vol 1.]
Book
with institutional author
11. Advisory Committee on Genetic Modification: Annual
Report. London; 1999.
PhD
thesis
12. Kohavi R: Wrappers for performance enhancement
and oblivious decision graphs. PhD thesis.
Stanford University, Computer Science Department;
1995.
Link
/ URL
13. Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]
-
Microsoft
Word template
Although we can accept manuscripts prepared as
Microsoft Word, Word Perfect, RTF (or PDF files with
pre-approval from jHASE), we
have designed a Microsoft Word template that can be
used to generate a standard style and format for
your article. This template needs to be used if you have not yet
started to write your paper or if it is already
written, your manuscript will need to be put into jHASE
style at the time of submission (PLEASE NOTE:
managing editor pre-approval is required for initial
submission of review versions of manuscripts
previously written in a different style, and this
will only be granted if the manuscript reasonably
contains all the key sections and elements of the
jHASE style, and only on condition that a final
revised manuscript version set to the jHASE style
using the template will be submitted for the final
round of review, if accepted with revisions).
Download
the template (Mac and Windows compatible Word
1998/2000) from our site, and save it to your hard
drive. For Windows users, right-click and select "save target
as" to save template on your computer or Double click the template to open it.
For
extra convenience, you can use the template as one of
your standard Word templates. To do this, put a copy
of the template file in Word's 'Templates' folder,
normally C:\Program Files\Microsoft Office\Templates
on a PC. The next time you create a new document in
Word using the File menu, the template will appear as
one of the available choices for a new document.
Note -
From version 6 and later, EndNote includes a full set of
structured article templates for BMC Public Health,
which are compatible with acceptable for jHASE
submissions. Users of EndNote are encouraged to upgrade
if necessary and make use of these templates. More
information is available
here.
|
| return
to top |
Preparing
illustrations and figures
In
addition to inserting/embedding illustrations in
the text file
of the Word template of the
submission manuscript at the appropriate locations
indicated in the
template,
illustrations should ALSO be provided and uploaded as
separate files
using formats described below.
This means that each figure should include a single
composite illustration, which should be a separate
graphics file inserted into the text and also provided
as a separate file in formats described below. There is no charge for the use of color
figures. Each figure should be closely cropped
to minimize the amount of white space surrounding the
illustration.
PLEASE
NOTE: As described above, if a
figure consists of separate parts, it is important that
a single composite illustration file be submitted
which contains all parts of the figure.
Photographs
should be provided with a scale bar if appropriate, as
well as high-resolution component files. If photographs
of patients' body parts, X-rays or scans are given as
part of the manuscript, written and signed consent of
the patient should also be scanned and e-mailed or faxed to the editors.
Scaling/resolution
Illustrations should be designed such that all
information is legible when scaled to a horizontal width
of 600 pixels, since this is the default size for a jHASE illustration on the web.
High-quality versions of figures will also be generated
and stored by jHASE, however, so image files
should be submitted at a resolution of 300 dpi or
greater if possible.
Text
within figures should use either Arial or Helvetica
fonts, although Courier may also be used if a monospaced
font is required. Text too should be designed to be
legible when the illustration is scaled to a width of
600 pixels.
Formats
The following file formats can be accepted for the
separate files of figures/illustrations submitted:
-
Insert figures into Microsoft
Word files (version 5 and above up to 2003; figures must be
A4 portrait, and not exceed a single page ); figures
may be inserted within the Word template of the
submission article or in a separate Word document;
-
Insert figures into PowerPoint files,
compatible with versions 2000 - 2003) (figures must be a single page);
-
PDF
(especially suitable for diagrams);
-
Other formats which may be considered (depending on
quality of figures submitted, poor quality figures may
be returned for resubmission in better formats):
-
JPEG (only if saved at High or Maximum quality);
- TIFF
- BMP
-
GIF (least preferred)
If the
large size of TIFF or BMP figures is an obstacle to
e-mail/online submission, authors may find that conversion to
JPEG format before submission results in significantly
reduced file size (and e-mail/online upload time), while retaining
acceptable quality. JPEG is a 'lossy' format, however.
In order to maintain acceptable image quality, it is
recommended that JPEG files are saved at High or Maximum
quality.
There is
not likely to be much gain in reducing file size from
use of file compression tools such as Zipit or
Stuffit prior to submission. These tools will in any
case produce negligible file-size savings for JPEGs and
TIFFs, which are already compressed.
Image
conversion tools
There are many software
packages, many of them freeware or shareware,
capable of converting to and from different graphics
formats, including PNG.
Good
general tools for image conversion include GraphicConverter
on the Macintosh, PaintShop
Pro, for Windows, and ImageMagick,
which is available on Macintosh, Windows and UNIX
platforms.
About
EPS format: Note
that bitmap images (e.g. screenshots) should not be
converted to EPS since this will result in a much larger
file size than the equivalent JPEG, TIFF, PNG or BMP,
with no increase in quality. EPS should only be used for
images produced by vector drawing applications such as
Adobe Illustrator or CorelDraw. In all instances, vector drawing
application images and EPS formats must be converted and
submitted in PDF format and not EPS format.
About
images
originally prepared in an Office application, such as
Word or PowerPoint, then the Office files should be
submitted in this Office application, rather than converted to
JPEG or another format that may be of reduced quality.
Figure
legends
The figure legends should be included in the main
manuscript text, immediately following the references,
rather than being a part of the figure file. The
following information should be provided, for each
figure: Figure number (in sequence, using Arabic
numerals - i.e. Figure 1, 2, 3 etc); short title of
figure (maximum 15 words); detailed legend, up to 300
words.
Please
Note: It is the responsibility of the author(s) to
obtain permission from the copyright holder to
reproduce figures or tables that have previously been
published elsewhere.
|
| return
to top |
Preparing
tables
As
described above under the section on illustrations,
in addition to inserting
tables in
the text file
of the Word template of the
submission manuscript at the appropriate locations
indicated in the
template,
tables should ALSO be provided and uploaded as separate
files as
described herein.
Each table should be
numbered in sequence using Arabic numerals (i.e. Table
1, 2, 3 etc.). Tables should also have a title that
summarizes the whole table, maximum 15 words. Detailed
legends may then follow, but should be concise.
As is
applicable to all tables, smaller
tables considered to be integral to the manuscript must
also be pasted into the document text file in
portrait format in
the text file
of the Word template of the
submission manuscript at the appropriate locations
for tables and figures indicated in the
template.
If the manuscript is accepted, jHASE will
also typeset and display such tables in
the final published form of the article. Such tables
should be formatted using the 'Table object' in a word
processing program to ensure that columns of data are
kept aligned when the file is sent electronically for
review; this will not always be the case if columns are
generated by simply using tabs to separate text, and
therefore, tabbed tables will not be accepted. Columns
and rows of data should be made visibly distinct by
ensuring the borders of each cell display as black
lines. Commas should not be used to indicate numerical
values. Color and shading should not be used in tables.
Larger
datasets can be uploaded separately as additional files.
Additional files will not be displayed in the final,
published form of the article, but a link will be
provided to the files as supplied by the author.
Tabular
datasets provided as additional files can be uploaded as an
Excel spreadsheet compatible with Excel 2000 - 2003 (.xls) or comma separated values (.csv).
As with all files, please use the standard file
extensions.
|
| return
to top |
|
Preparing
additional files
Although
jHASE does not restrict the length and quantity
of data in a paper, there may still be occasions where
an author wishes to provide data sets, tables, movie
files, or other information as additional information.
These files can be uploaded using the 'Additional
Material files' button in the manuscript submission
process.
The
maximum file size for additional files is 10 MB, and
files will be virus-scanned on submission. If additional
files exceed 5 MB, authors are kindly requested to Zip
the additional files (without password protection) and
send the Zip file containing the additional files as an
attachment to e-mail.
Any
additional files will be linked into the final published
article in the form supplied by the author, but will not
be displayed within the paper. They will be made
available in exactly the same form as originally
provided.
If
additional material is provided, please list the
following information in a separate section of the
manuscript text, immediately following the tables (if
any):
- File
name
- File
format (including name and a URL of an appropriate
viewer if format is unusual)
- Title
of data
- Description
of data
Additional
datafiles should be referenced explicitly by file name
within the body of the article, e.g. 'See additional
file 1: Movie1 for the original data used to perform
this analysis'.
Formats
and uploading
Ideally, file formats for additional files should not be
platform-specific, and should be viewable using free or
widely available tools. The following are examples of
suitable formats.
- Additional
documentation
- Animations
- Movies
- MOV
(QuickTime)
- MPG
(MPEG)
- Tabular
data
- XLS
(Excel spreadsheet)
- CSV
(Comma separated values)
As with
figure files, files should be given the standard file
extensions. This is especially important for Macintosh
users, since the Mac OS does not enforce the use of
standard extensions. Please also make sure that each
additional file is a single table, figure or movie
(please do not upload linked worksheets or PDF files
larger than one sheet).
|
| return
to top |
Style
and language
General
Currently, jHASE can only accept manuscripts
written in English. Spelling should be US English or
British English, but not a mixture.
Gene
names should be in italic, but protein products should
be in plain type.
There is
no explicit limit on the length of articles submitted,
but authors are encouraged to be concise. There is also
no restriction on the number of figures, tables or
additional files that can be included with each article
online. Figure and tables should be sequentially
referenced. Authors should include all relevant
supporting data with each article.
jHASE
will not edit submitted manuscripts for style or
language; reviewers may advise rejection of a manuscript
if it is compromised by grammatical errors. Authors are
advised to write clearly and simply, and to have their
article checked by colleagues before submission.
In-house copyediting will be minimal. Non-native
speakers of English may choose to make use of a
copyediting service such as that provided by Biology
Editors, Manuscript
Presentation Service, International
Science Editing and English
Manager Science Editing. jHASE has no
first-hand experience of these companies and takes no
responsibility for the quality of their service.
Help
and advice on scientific writing
MedBioWorld
also provides a list of resources for science writing. Tim Albert has produced for BioMed Central a
list
of tips for writing a scientific manuscript.
Abbreviations
Abbreviations should be used as sparingly as possible.
They can be defined when first used or a list of
abbreviations can be provided preceding the
acknowledgements and references.
Typography
- Please
use double line spacing.
- Type
the text unjustified, without hyphenating words at
line breaks.
- Use
hard returns only to end headings and paragraphs,
not to rearrange lines.
- All
pages should be numbered and page numbering must be
centered and located in the footer of the document.
- Use
the jHASE reference format.
- Footnotes
to text should not be used.
- Greek
and other special characters may be included. If you
are unable to reproduce a particular special
character, please type out the name of the symbol in
full. Please ensure that all special characters
used are embedded in the text, otherwise they will
be lost during conversion to PDF.
Units
SI Units should be used throughout (litre and molar are
permitted, however).
Last
revised: 4 April 2009 |
| return
to top |
|